Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer

Autor: Ganem, G. *, Tubiana-Hulin, M., Fumoleau, P., Combe, M., Misset, J.-L., Vannetzel, J.-M., Bachelot, T., De Ybarlucea, L.R., Lotz, V., Bendahmane, B., Dieras, V.
Zdroj: In Annals of Oncology November 2003 14(11):1623-1628
Databáze: ScienceDirect